These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 16409143)
1. The rotavirus vaccine saga. Shaw AR Annu Rev Med; 2006; 57():167-80. PubMed ID: 16409143 [TBL] [Abstract][Full Text] [Related]
2. Update on Rotarix: an oral human rotavirus vaccine. O'Ryan M; Linhares AC Expert Rev Vaccines; 2009 Dec; 8(12):1627-41. PubMed ID: 19943758 [TBL] [Abstract][Full Text] [Related]
3. Development of a rotavirus vaccine: clinical safety, immunogenicity, and efficacy of the pentavalent rotavirus vaccine, RotaTeq. Ciarlet M; Schödel F Vaccine; 2009 Dec; 27 Suppl 6():G72-81. PubMed ID: 20006144 [TBL] [Abstract][Full Text] [Related]
4. Vaccines. Rotavirus vaccines' second chance. Roberts L Science; 2004 Sep; 305(5692):1890-3. PubMed ID: 15448237 [No Abstract] [Full Text] [Related]
10. Rotavirus vaccines: entering a new stage of deployment. Nakagomi O; Cunliffe NA Curr Opin Infect Dis; 2007 Oct; 20(5):501-7. PubMed ID: 17762784 [TBL] [Abstract][Full Text] [Related]
11. The new pentavalent rotavirus vaccine composed of bovine (strain WC3) -human rotavirus reassortants. Clark HF; Offit PA; Plotkin SA; Heaton PM Pediatr Infect Dis J; 2006 Jul; 25(7):577-83. PubMed ID: 16804425 [TBL] [Abstract][Full Text] [Related]
12. Safety of the pentavalent rotavirus vaccine (PRV), RotaTeq(®), in Kenya, including among HIV-infected and HIV-exposed infants. Laserson KF; Nyakundi D; Feikin DR; Nyambane G; Cook E; Oyieko J; Ojwando J; Rivers SB; Ciarlet M; Neuzil KM; Breiman RF Vaccine; 2012 Apr; 30 Suppl 1():A61-70. PubMed ID: 22520138 [TBL] [Abstract][Full Text] [Related]
13. Second-year follow-up evaluation of live, attenuated human rotavirus vaccine 89-12 in healthy infants. Bernstein DI; Sack DA; Reisinger K; Rothstein E; Ward RL J Infect Dis; 2002 Nov; 186(10):1487-9. PubMed ID: 12404166 [TBL] [Abstract][Full Text] [Related]
14. Acute rotavirus gastroenteritis in children younger than 5 years of age after initiation of rotavirus immunization schedule. García-Puebla A; García-Fragoso L Bol Asoc Med P R; 2012; 104(1):4-7. PubMed ID: 22788071 [TBL] [Abstract][Full Text] [Related]
15. Dose response and efficacy of a live, attenuated human rotavirus vaccine in Mexican infants. Ruiz-Palacios GM; Guerrero ML; Bautista-Márquez A; Ortega-Gallegos H; Tuz-Dzib F; Reyes-González L; Rosales-Pedraza G; Martínez-López J; Castañón-Acosta E; Cervantes Y; Costa-Clemens S; DeVos B Pediatrics; 2007 Aug; 120(2):e253-61. PubMed ID: 17606534 [TBL] [Abstract][Full Text] [Related]
16. Safety, efficacy, and immunogenicity of 2 doses of bovine-human (UK) and rhesus-rhesus-human rotavirus reassortant tetravalent vaccines in Finnish children. Vesikari T; Karvonen AV; Majuri J; Zeng SQ; Pang XL; Kohberger R; Forrest BD; Hoshino Y; Chanock RM; Kapikian AZ J Infect Dis; 2006 Aug; 194(3):370-6. PubMed ID: 16826486 [TBL] [Abstract][Full Text] [Related]
17. Impact of rotavirus vaccines on rotavirus disease. Lepage P; Vergison A Expert Rev Anti Infect Ther; 2012 May; 10(5):547-61. PubMed ID: 22702319 [TBL] [Abstract][Full Text] [Related]
18. Preventing rotavirus gastroenteritis: do you have the facts? Davidson G; Elliott EJ; Kirkwood C; Pearce R J Paediatr Child Health; 2007; 43(7-8):564-7. PubMed ID: 17635688 [TBL] [Abstract][Full Text] [Related]
19. Estimating rotavirus vaccine effectiveness in Japan using a screening method. Araki K; Hara M; Sakanishi Y; Shimanoe C; Nishida Y; Matsuo M; Tanaka K Hum Vaccin Immunother; 2016 May; 12(5):1244-9. PubMed ID: 26680277 [TBL] [Abstract][Full Text] [Related]
20. Rotavirus disease and its prevention. Widdowson MA; Bresee JS; Gentsch JR; Glass RI Curr Opin Gastroenterol; 2005 Jan; 21(1):26-31. PubMed ID: 15687881 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]